STELARA receives European Commission approval for treatment of adolescents with moderate-to-severe psoriasis In Europe

Janssen-Cilag International NV ("Janssen") has announced that the European Commission (EC) has approved STELARA® (ustekinumab) for the treatment of moderate-to-severe plaque psoriasis in...